Guangzhou-based cancer diagnostic start-up Burning Rock Biotech has completed RMB150 million (US$23 million) series A+ round of funding from Jifeng Capital, Sequoia Capital and Legend Star, according to a company announcement. The company says it will use the proceeds on its research and development efforts, as well as developing new products to meet patient demand. […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.